Clinical trial
Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells
NCT04325594 is registered in ClinicalTrials.gov with The Research-Clinical Center for Cardiac Surgery and Transplantology LLP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells
- Lead sponsor
- The Research-Clinical Center for Cardiac Surgery and Transplantology LLP
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- April 1, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, non-ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy